Literature DB >> 26190570

Role of Sociodemographic, Co-morbid and Intraoperative Factors in Length of Stay Following Primary Total Hip Arthroplasty.

Ifeoma A Inneh1, Richard Iorio1, James D Slover1, Joseph A Bosco1.   

Abstract

We aimed to examine and quantify the combined association of patient sociodemographic, preoperative comorbidities and intraoperative factors with extended and prolonged length of stay (LOS) following primary total hip arthroplasty. Longer LOS was associated with Age (≥65 years), BMI ≥30 kg/m(2), ASA score >2, minority race/ethnicity, low SES, general anesthesia, comorbidities of the Circulatory, Genitourinary and Respiratory systems, and operating time. Collectively, being of low SES, advanced age (≥65 years) and minority race/ethnicity was most significantly associated with prolonged LOS (>7 days). The combined associations of lower SES, female gender, advanced age, non-Caucasian race/ethnicity and certain comorbidities presented a synergistically elevated risk for longer LOS and may warrant the need to consider sociodemographic status when allocating resources to hospitals serving such patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SES; THA; hip arthroplasty; length of stay; long length of hospital stay; socioeconomic status

Mesh:

Year:  2015        PMID: 26190570     DOI: 10.1016/j.arth.2015.06.054

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  CORR Synthesis: How Might the Preoperative Management of Risk Factors Influence Healthcare Disparities in Total Joint Arthroplasty?

Authors:  Chloe C Dlott; Daniel H Wiznia
Journal:  Clin Orthop Relat Res       Date:  2022-03-18       Impact factor: 4.755

2.  Rehabilitation After Total Knee Arthroplasty: Do Racial Disparities Exist?

Authors:  Alyson M Cavanaugh; Mitchell J Rauh; Caroline A Thompson; John E Alcaraz; Chloe E Bird; Todd P Gilmer; Andrea Z LaCroix
Journal:  J Arthroplasty       Date:  2019-11-02       Impact factor: 4.757

3.  Association between same day discharge total knee and total hip arthroplasty and risks of cardiac/pulmonary complications and readmission: a population-based observational study.

Authors:  Jiabin Liu; Nabil Elkassabany; Jashvant Poeran; Alejandro Gonzalez Della Valle; David H Kim; Daniel Maalouf; Stavros Memtsoudis
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

4.  Neighborhood-Level Socioeconomic Deprivation, Rurality, and Long-Term Outcomes of Patients Undergoing Total Joint Arthroplasty: Analysis from a Large, Tertiary Care Hospital.

Authors:  Celia C Kamath; Thomas J O'Byrne; David G Lewallen; Daniel J Berry; Hilal Maradit Kremers
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-01

Review 5.  Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management.

Authors:  Angel M Reyes; Jeffrey N Katz
Journal:  Rheum Dis Clin North Am       Date:  2020-10-29       Impact factor: 2.670

6.  Does BMI influence hospital stay and morbidity after fast-track hip and knee arthroplasty?

Authors:  Henrik Husted; Christoffer C Jørgensen; Kirill Gromov; Henrik Kehlet
Journal:  Acta Orthop       Date:  2016-06-27       Impact factor: 3.717

7.  Economic Disparities in Patients Undergoing Sigmoidectomy.

Authors:  Sean Neifert; Nicole Ilonzo; Jeanie L Gribben; I Michael Leitman
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

8.  Limited Influence of Comorbidities on Length of Stay after Total Hip Arthroplasty: Experience of Enhanced Recovery after Surgery.

Authors:  Zi-Chuan Ding; Bing Xu; Zhi-Min Liang; Hao-Yang Wang; Ze-Yu Luo; Zong-Ke Zhou
Journal:  Orthop Surg       Date:  2019-12-29       Impact factor: 2.071

9.  Is performing joint arthroplasty surgery during the COVID-19 pandemic safe?: A retrospective, cohort analysis from a tertiary centre in NCR, Delhi, India.

Authors:  Om Prakash Meena; Pulkit Kalra; Ajay Shukla; Ananta Kumar Naik; Karthikeyan P Iyengar; Vijay Kumar Jain
Journal:  J Clin Orthop Trauma       Date:  2021-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.